Bromadol, an recently created pain reliever, has unique biological characteristics. It primarily functions through the limited mu-opioid binding site activator, however demonstrates considerable influence with the kappa-opioid binding site as also. This mixed influence leads to in the complex profile of consequences, such as analgesia, drowsines